AGOSTINELLI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 14.214
AS - Asia 11.890
EU - Europa 9.106
SA - Sud America 766
AF - Africa 726
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 36.723
Nazione #
US - Stati Uniti d'America 14.003
SG - Singapore 3.262
CN - Cina 3.065
VN - Vietnam 3.020
GB - Regno Unito 2.308
IT - Italia 1.541
DE - Germania 1.233
SE - Svezia 994
HK - Hong Kong 788
IN - India 672
FR - Francia 640
BR - Brasile 537
RU - Federazione Russa 531
UA - Ucraina 420
IE - Irlanda 336
ZA - Sudafrica 265
JP - Giappone 201
NL - Olanda 185
FI - Finlandia 169
BD - Bangladesh 156
CH - Svizzera 155
EE - Estonia 153
CI - Costa d'Avorio 152
KR - Corea 148
TG - Togo 130
CA - Canada 114
AR - Argentina 102
BG - Bulgaria 75
ID - Indonesia 71
AT - Austria 63
JO - Giordania 63
PH - Filippine 58
TR - Turchia 58
TH - Thailandia 53
MX - Messico 50
NG - Nigeria 49
BE - Belgio 48
PL - Polonia 48
SC - Seychelles 41
PK - Pakistan 37
IQ - Iraq 34
TW - Taiwan 33
EC - Ecuador 32
IR - Iran 32
ES - Italia 30
HR - Croazia 28
CL - Cile 27
LB - Libano 25
LU - Lussemburgo 25
CO - Colombia 24
LT - Lituania 23
SA - Arabia Saudita 23
GR - Grecia 22
UZ - Uzbekistan 22
EG - Egitto 14
JM - Giamaica 14
MY - Malesia 13
VE - Venezuela 13
AU - Australia 12
MA - Marocco 12
PY - Paraguay 11
RO - Romania 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
HU - Ungheria 9
KE - Kenya 9
PE - Perù 9
DZ - Algeria 8
IL - Israele 8
PT - Portogallo 8
AL - Albania 7
ET - Etiopia 7
NP - Nepal 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
LV - Lettonia 5
AO - Angola 4
CR - Costa Rica 4
DK - Danimarca 4
OM - Oman 4
SI - Slovenia 4
BO - Bolivia 3
BY - Bielorussia 3
GH - Ghana 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SO - Somalia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
Totale 36.669
Città #
Singapore 2.168
Southend 2.002
Fairfield 1.437
Ashburn 1.424
Chandler 899
Hong Kong 741
Woodbridge 713
San Jose 704
Houston 701
Wilmington 664
Ho Chi Minh City 647
Seattle 611
Hanoi 555
Princeton 546
Cambridge 503
Ann Arbor 457
Beijing 432
Santa Clara 409
Dong Ket 401
Bologna 336
Dublin 335
Boardman 326
Hefei 287
Lauterbourg 271
Nanjing 238
Los Angeles 220
Westminster 211
Jacksonville 197
New York 192
Padova 182
Tokyo 178
Abidjan 152
Dallas 143
Bremen 137
Helsinki 137
Berlin 134
Milan 132
Lomé 129
Bern 126
Jinan 120
Seoul 116
Buffalo 114
Saint Petersburg 114
Da Nang 108
Shenyang 99
Haiphong 93
Redondo Beach 90
Council Bluffs 89
Nanchang 86
Redmond 86
London 82
Changsha 78
Frankfurt am Main 75
Hebei 75
São Paulo 75
San Diego 74
Sofia 74
Guangzhou 72
Hyderabad 69
Chicago 66
Tianjin 65
Mülheim 64
Amman 61
Hangzhou 61
Medford 59
Johannesburg 58
Zhengzhou 57
Jiaxing 56
Falls Church 51
Phoenix 49
Brussels 47
Abeokuta 46
Munich 43
Rome 42
Shanghai 42
Haikou 40
Orem 40
Redwood City 40
Turin 40
Yubileyny 39
Jakarta 38
Toronto 38
Montreal 37
Vienna 37
Dearborn 35
Taizhou 35
Can Tho 34
Norwalk 33
San Venanzo 33
The Dalles 33
Warsaw 33
Des Moines 32
Hải Dương 32
Ningbo 30
Nuremberg 29
Olalla 29
Taiyuan 29
Bengaluru 28
Amsterdam 27
Chennai 27
Totale 23.581
Nome #
ANALYSIS OF THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA REVEALS MUTATIONAL ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DIFFERENTIATION 327
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 289
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 286
Biology and treatment of follicular lymphoma. 282
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 277
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 272
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 268
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 258
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma – Authors' reply 256
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 252
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 250
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 243
IFI16 expression is related to selected transcription factors during B-cell differentiation 231
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 228
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 222
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 222
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report 222
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 221
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. 218
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 218
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 215
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 210
RALE051: a novel established cell line of sporadic Burkitt lymphoma 209
Expression of CD52 in peripheral T-cell lymphoma. 208
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 208
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment 206
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 200
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 200
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 199
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 196
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). 195
CD30 expression in peripheral T-cell lymphomas 195
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES 195
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 194
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 192
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 192
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 191
Histopathology of B-cell chronic lymphocytic leukemia. 190
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 190
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. 186
Photodynamic therapy: An option in mycosis fungoides 185
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 184
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 183
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis 183
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 182
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 181
Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long term follow up and literature review 181
Anaplastic Large Cell Lymphoma: a critical reappraisal 180
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 180
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma 179
BCL10 down-regulation in peripheral T-cell lymphomas. 179
Pathobiology of hodgkin lymphoma. 179
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 178
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 177
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 175
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 175
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes 174
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 173
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 172
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. 171
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 171
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 170
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 170
Pathobiology of anaplastic large cell lymphoma. 170
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 170
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. 169
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups 169
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 168
Cutaneous adverse-events in patients treated with Ibrutinib 167
A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp. 166
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 166
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 166
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 164
Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder 164
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 162
Granulomatous tattoo reaction in a nivolumab-treated patient 162
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 161
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 161
Pathobiology of ALK-negative anaplastic large cell lymphoma. 160
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. 159
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 159
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 158
Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study 158
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters 158
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation 157
CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma 157
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 156
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 156
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 155
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 154
Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. 154
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 153
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 152
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 152
Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm. 150
Peripheral T-cell lymphomas not otherwise specified correspond to distinct mature T-cell populations basing on the global gene expression profile. 150
Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report. 149
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. 148
Primary cutaneous lymphomas: a reprisal 148
Prognostic markers in peripheral T-cell lymphoma. 146
Totale 18.969
Categoria #
all - tutte 106.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021910 0 0 0 0 0 0 0 0 0 0 0 910
2021/20224.099 314 151 240 284 436 242 80 282 208 351 889 622
2022/20234.424 539 603 251 599 335 334 132 243 711 104 320 253
2023/20241.240 64 229 116 105 109 227 89 82 43 87 36 53
2024/20254.668 232 878 447 368 664 232 404 144 55 229 176 839
2025/202611.966 826 975 1.090 1.010 1.405 716 1.263 414 2.426 1.038 462 341
Totale 37.451